Colin F. Spraggs

<i>HLA-DQA1</i> * <i>02:01</i> Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer

Colin F. Spraggs, L. R. Budde, Linda P. Briley et al. · Journal of Clinical Oncology · 2011 · 277 citations

Medicine, Genetics, Oncology +17

Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery

Pierre Diemunsch, P. Schoeffler, B. Bryssine et al. · British Journal of Anaesthesia · 1999 · 167 citations · Full text

Medicine, Pharmacotherapy, Surgery +13

Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes

Chun‐Fang Xu, Nan Bing, Howard Ball et al. · Journal of Clinical Oncology · 2011 · 149 citations · Full text

Medicine, Genetics, Oncology +17

Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism

Chun‐Fang Xu, Brian H. Reck, Zhengyu Xue et al. · British Journal of Cancer · 2010 · 120 citations · Full text

Medicine, Oncology, Pharmacology +15

<i>HLA-B</i> *57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer

Chun‐Fang Xu, Toby Johnson, Xiaojing Wang et al. · Clinical Cancer Research · 2015 · 95 citations · Full text

Medicine, Oncology, Pharmacology +16